MedElevator
Войти в исследования Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2015
[Emotional and personality disorders in atypical facial pain].
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Maximova M Yu, Suanova E T
Аннотация
OBJECTIVE: To investigate emotional and personality disorders in patients with atypical facial pain.
MATERIAL AND METHODS: Forty-five patients (42 women, 3 men, mean age 50±16 years) were examined. Pain severity was assessed with the Visual Analogue Scale. Anxiety and depression levels were measured with the Zung Self-Rating Depression Scale, the State-Trait Anxiety Inventory (Spilberg's tests), the Taylor Manifest Anxiety Scale, The Beck Depression Inventory. Thirty patients with atypical facial pain were treated with noophen. The clinical state of the patients was assessed with the Hamilton Depression Rating Scale (HAM-D). Noophen was administrated in daily dose of 500 mg, the course of the treatment was 8 weeks.
RESULTS AND CONCLUSION: Anxiety and depression as well as the domination of functional neurologic symptoms were characteristic of patients with atypical facial pain. Anxiolytic and antidepressive effects of noophen were seen from the 21st day of treatment. A mild stimulation effect and sleep normalization were also observed. An improvement of the mental state was found in 70% patients with atypical facial pain in the end of treatment: 50% patients demonstrated a significant improvement.
MATERIAL AND METHODS: Forty-five patients (42 women, 3 men, mean age 50±16 years) were examined. Pain severity was assessed with the Visual Analogue Scale. Anxiety and depression levels were measured with the Zung Self-Rating Depression Scale, the State-Trait Anxiety Inventory (Spilberg's tests), the Taylor Manifest Anxiety Scale, The Beck Depression Inventory. Thirty patients with atypical facial pain were treated with noophen. The clinical state of the patients was assessed with the Hamilton Depression Rating Scale (HAM-D). Noophen was administrated in daily dose of 500 mg, the course of the treatment was 8 weeks.
RESULTS AND CONCLUSION: Anxiety and depression as well as the domination of functional neurologic symptoms were characteristic of patients with atypical facial pain. Anxiolytic and antidepressive effects of noophen were seen from the 21st day of treatment. A mild stimulation effect and sleep normalization were also observed. An improvement of the mental state was found in 70% patients with atypical facial pain in the end of treatment: 50% patients demonstrated a significant improvement.